These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32172653)

  • 1. Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease.
    Golledge J; Rowbotham S; Velu R; Quigley F; Jenkins J; Bourke M; Bourke B; Thanigaimani S; Chan DC; Watts GF
    J Am Heart Assoc; 2020 Mar; 9(6):e015355. PubMed ID: 32172653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease.
    Sanchez Muñoz-Torrero JF; Rico-Martín S; Álvarez LR; Aguilar E; Alcalá JN; Monreal M;
    Atherosclerosis; 2018 Sep; 276():10-14. PubMed ID: 30006322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between stress hormones and perioperative risk in patients with critical limb ischemia undergoing revascularization.
    Soga Y; Takahara M; Iida O; Kodama A; Azuma N;
    J Vasc Surg; 2019 Sep; 70(3):795-805.e1. PubMed ID: 30857850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of High Lipoprotein(a) Levels on Clinical Outcomes Following Peripheral Endovascular Therapy.
    Tomoi Y; Takahara M; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
    JACC Cardiovasc Interv; 2022 Jul; 15(14):1466-1476. PubMed ID: 35863797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis.
    Forbang NI; Criqui MH; Allison MA; Ix JH; Steffen BT; Cushman M; Tsai MY
    J Vasc Surg; 2016 Feb; 63(2):453-8. PubMed ID: 26518096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Bonadia N; Bruno P; Angelini F; Di Stasi C; Contegiacomo A; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Sep; 19(1):147. PubMed ID: 32977814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease.
    Singh TP; Morris DR; Smith S; Moxon JV; Golledge J
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):220-233. PubMed ID: 28666785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study.
    Gurdasani D; Sjouke B; Tsimikas S; Hovingh GK; Luben RN; Wainwright NW; Pomilla C; Wareham NJ; Khaw KT; Boekholdt SM; Sandhu MS
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3058-65. PubMed ID: 23065826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
    Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
    J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative cardiovascular complications rate and activity of coagulation and fibrinolysis among patients undergoing vascular surgery for peripheral artery disease and abdominal aortic aneurysm.
    Polok K; Górka J; Fronczek J; Iwaniec T; Górka K; Szczeklik W
    Vascular; 2021 Feb; 29(1):134-142. PubMed ID: 32600160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events.
    Thomas PE; Vedel-Krogh S; Nielsen SF; Nordestgaard BG; Kamstrup PR
    J Am Coll Cardiol; 2023 Dec; 82(24):2265-2276. PubMed ID: 38057068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
    Zierfuss B; Höbaus C; Feldscher A; Hannes A; Mrak D; Koppensteiner R; Stangl H; Schernthaner GH
    Atherosclerosis; 2022 Dec; 363():94-101. PubMed ID: 36280470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.
    Desai U; Kharat A; Hess CN; Milentijevic D; Laliberté F; Zuckerman P; Benson J; Lefebvre P; Hiatt WR; Bonaca MP
    Ann Vasc Surg; 2021 Aug; 75():217-226. PubMed ID: 33819600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study.
    Szczeklik W; Krzanowski M; Maga P; Partyka Ł; Kościelniak J; Kaczmarczyk P; Maga M; Pieczka P; Suska A; Wachsmann A; Górka J; Biccard B; Devereaux PJ
    Clin Res Cardiol; 2018 Apr; 107(4):319-328. PubMed ID: 29177795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editor's Choice - Cohort Study Examining the Association Between Abdominal Aortic Size and Major Adverse Cardiovascular Events in Patients with Aortic and Peripheral Occlusive and Aneurysmal Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Eur J Vasc Endovasc Surg; 2021 Dec; 62(6):960-968. PubMed ID: 34740532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
    Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.